AVXLClinical Trials•globenewswire•
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
Sentiment:Positive (70)
Summary
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 20, 2025 by globenewswire